Subsequent Events (Details) - USD ($) $ / shares in Units, $ in Millions |
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
Jan. 31, 2021 |
Dec. 31, 2020 |
Aug. 31, 2015 |
|
| Subsequent Event [Line Items] | |||
| Number of warrants to purchase | 1,112,313 | ||
| Net cash proceeds | $ 8.9 | ||
| 2015 Plan | |||
| Subsequent Event [Line Items] | |||
| Authorized shares | 55,556 | ||
| Subsequent Events | 2015 Plan | |||
| Subsequent Event [Line Items] | |||
| Authorized shares | 1,000,000 | ||
| Subsequent Events | January 2021 Offering | |||
| Subsequent Event [Line Items] | |||
| Issuance of common stock, net (in shares) | 2,725,000 | ||
| Number of warrants to purchase | 2,725,000 | ||
| Exercise price of warrants (in dollars per share) | $ 3.55 | ||
| Net cash proceeds | $ 8.9 |
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares authorized for issuance under share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|